EN
HI
Bafna Pharmaceuticals Chart
Bafna Pharmaceuticals Share Key Metrics
Volume
26556.00
Market Cap
378.95 CR
LTQ@LTP
5@168.19
ATP
166.66
Var Margin
100 %
Circuit Range
152.19-168.19
Delivery %
0 %
Value
44.26 L
ASM/GSM
No
Market Lot
1
Summary
Bafna Pharmaceuticals share price is ₹168.19 as of 22 Jun, 2026. The stock Bafna Pharmaceuticals intraday movement has stayed between ₹160.51 and ₹168.19, while on a 52-week basis,Bafna Pharmaceuticals price 52 week high is ₹213.36 & its 52 week low is ₹73.01.
In terms of trading activity, Bafna Pharmaceuticals has recorded a volume of 26556 shares, The Bafna Pharmaceuticals has a market cap of ₹23656335 CR. The stock’s Average Traded Price (ATP) stands at ₹166.66, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 5 @ ₹168.19.
Bafna Pharmaceuticals operates within a circuit range of ₹152.19 – ₹168.19, with a Value of ₹44.26 L. The Delivery Percentage for the day is 0%. Additionally, Bafna Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.
Bafna Pharmaceuticals Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
69.22
Sector P/B
3.07
Sec. Div. Yield
0.53
Bafna Pharmaceuticals Resistance and Support
Pivot 158.75
Resistance
First Resistance
163.51
Second Resistance
166.83
Third Resistance
171.59
Support
First Support
155.43
Second Support
150.67
Third Support
147.35
Bafna Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-11 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-05-26 | Audited Results |
| 2025-02-06 | Quarterly Results |
Bafna Pharmaceuticals News
Bafna Pharmaceuticals Ltd - 532989 - Board Meeting Outcome for Outcome Of The Board Meeting Held On May 29, 2026
Bafna Pharmaceuticals approved Q4 FY26 and full year FY26 audited financial results. Q4 total income increased 9.77% YoY to ₹44.00 crore, with net profit up 109.69% YoY to ₹2.75 crore. Auditors issued an unmodified opinion for the financial results.
May 29 2026 18:39:03
Bafna Pharmaceuticals Management
| Name | Position |
|---|---|
| Shanmugam Hemalatha | Whole Time Director |
| Vinayak Dinesh Dendukuri | Whole Time Director - Quality |
Bafna Pharmaceuticals FAQs
The Buying Price of Bafna Pharmaceuticals share is 168.19 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Bafna Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Bafna Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Bafna Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Bafna Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.
To assess Bafna Pharmaceuticals’s valuation compare Sector P/E, P/B which are 69.22 & 3.07 with sector averages, along with growth rates and financial metrics.
The Market Cap of Bafna Pharmaceuticals is 378.95 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Bafna Pharmaceuticals share price is 213.36 & 73.01. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Bafna Pharmaceuticals belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
